Your Brain's Appetite Thermostat — NEGR1 and Obesity Risk
NEGR1 (Neuronal Growth Regulator 1) encodes a
GPI-anchored cell adhesion molecule | Glycosylphosphatidylinositol — a lipid anchor that attaches proteins to the outer surface of cell membranes
belonging to the IgLON family. It is strongly expressed in the
hypothalamus — the brain region that governs hunger, satiety, and
energy balance. The rs2815752 variant sits upstream of NEGR1 and
alters its expression, making it one of the first obesity-associated
genes identified by genome-wide association studies that pointed to a
neuronal, rather than metabolic, mechanism for weight gain.
The Mechanism
NEGR1 promotes neurite outgrowth, synapse formation, and cell-cell
adhesion in hypothalamic neurons, particularly in the
arcuate nucleus | The arcuate nucleus contains hunger-promoting (AgRP/NPY) and satiety-promoting (POMC) neurons that integrate signals from hormones like leptin and ghrelin
and ventromedial hypothalamus. It accumulates at GABAergic inhibitory
synapses and promotes clustering of
GAD65 | Glutamic acid decarboxylase 65 — the enzyme that synthesizes GABA, the main inhibitory neurotransmitter
at synaptic membranes. When NEGR1 expression is reduced — as occurs
with the A risk allele — hypothalamic appetite circuits are disrupted:
the GABAergic synaptic architecture weakens, and the brain's ability
to regulate food intake diminishes.
A linked 45-kb deletion polymorphism upstream of NEGR1 removes several
conserved regulatory elements, likely explaining how the common risk
haplotype reduces NEGR1 expression.
| Willer et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet, 2009
The Evidence
The NEGR1 locus was identified in the landmark
GIANT consortium GWAS | Willer et al. Meta-analysis of 15 GWAS for BMI (n>32,000) with replication in 14 cohorts (n>59,000). Nat Genet, 2009
as one of six new BMI loci, with the A allele increasing BMI by 0.10
kg/m2 per copy (P = 6.0 x 10-8, combined n = 83,499). The largest
BMI meta-analysis to date
(339,224 individuals | Locke et al. Genetic studies of body mass index yield new insights for obesity biology. Nature, 2015)
confirmed NEGR1 among 97 genome-wide significant loci and highlighted
its central nervous system expression pattern.
Mouse studies validate the human genetics. NEGR1-knockout mice show
reduced body mass (8-13%) | Lee et al. Functional inactivation of the GWAS obesity gene NEGR1 in mice causes a body mass phenotype. PLOS ONE, 2012,
decreased food intake, and reduced lean mass — confirming NEGR1's
role in appetite and body composition. In rats,
decreased hypothalamic NEGR1 expression | Boender et al. The obesity-associated gene Negr1 regulates aspects of energy balance in rat hypothalamic areas. Physiol Genomics, 2014
directly increases body weight and food intake, particularly affecting
carbohydrate preference.
In a human dietary study of 26,107 participants, the
A risk allele was associated with lower fat intake but higher carbohydrate and fiber intake | Rukh et al. Genetic susceptibility to obesity and diet intakes in the Malmö Diet and Cancer Study. Genes Nutr, 2013,
suggesting NEGR1 influences not just how much we eat but what we
prefer to eat.
Practical Actions
Because the A allele is extremely common (carried by 86% of
Europeans and over 99% of East Asians as at least one copy), this is
not a rare high-impact variant — it is a common, moderate-effect
contributor to obesity susceptibility. The practical value lies in
understanding your position on the appetite regulation spectrum.
Carriers of two A alleles should focus on structured meal timing and
protein-forward meals to support satiety signaling that their
hypothalamic wiring handles less efficiently. Monitoring waist
circumference rather than just body weight captures the metabolic
risk more accurately.
Interactions
NEGR1 contributes to a polygenic obesity risk profile alongside FTO
(rs9939609) and MC4R (rs17782313). While each variant has a modest
individual effect, carrying risk alleles at multiple loci has a
cumulative impact on BMI. A combined FTO + NEGR1 risk genotype may
warrant more structured appetite management strategies than either
alone.
NEGR1 is also a cross-trait hit for major depressive disorder, with
integrative genomic analysis | Li et al. Integrating GWAS and eQTL data identifies NEGR1 as a causal risk gene of major depression. J Affect Disord, 2020
identifying it as a causal MDD risk gene. The shared neurodevelopmental
mechanism — disrupted synaptic connectivity in hypothalamic and
limbic circuits — may explain why obesity and depression so often
co-occur. Carriers of the A allele at rs2815752 who also carry
depression-associated variants may experience compounded effects on
both appetite regulation and mood.
All Genotypes
No risk alleles — intact hypothalamic appetite regulation
You carry two copies of the protective G allele at rs2815752. Only about 14% of Europeans have this genotype — you are in the minority with the most robust NEGR1 expression in the hypothalamus. Your appetite regulation circuitry functions at full capacity. NEGR1 maintains normal GABAergic synaptic architecture in your arcuate nucleus and ventromedial hypothalamus, supporting efficient satiety signaling after meals. This does not make you immune to weight gain from environmental factors, but your neurological appetite thermostat is set at its most effective.
One risk allele — mildly reduced appetite regulation
You carry one A allele and one protective G allele at rs2815752. About 47% of Europeans share this genotype, making it the most common configuration in Western populations. With one copy of the risk allele, you have intermediate NEGR1 expression — better appetite regulation than AA carriers but not quite as robust as GG. The per-allele BMI effect is approximately 0.10 kg/m^2, a modest shift that becomes meaningful over a lifetime, especially in combination with other obesity-related variants.
Two risk alleles — reduced hypothalamic appetite control
You carry two copies of the A allele at rs2815752, which reduces NEGR1 expression in the hypothalamus and weakens your brain's appetite regulation circuitry. About 39% of Europeans share this genotype, rising to approximately 85% of East Asians — making it the most common genotype in many populations. With two copies, the per-allele BMI effect compounds: on average, 0.20 kg/m^2 higher BMI compared to GG carriers. While this seems small, it reflects a systematic shift in appetite signaling that, over decades, contributes meaningfully to weight gain — particularly when combined with other obesity risk variants. Research shows your genotype is associated with a preference for carbohydrate-rich foods and lower spontaneous fat intake, reflecting altered hypothalamic signaling for macronutrient selection.